Yes. DR-70/ CIT seems to weave its way into a lot of various research. We need the patent sresolved, and look for the news to appear. Regardless of what some people will say, RXPC has retained ownership of both and will be the primary beneficiary of same.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.